MET 8-K Current Reports
METLIFE INC - 684 current reports
METLIFE INC 8-K Report, Regulation FD Disclosure (Jun 29, 2026)
MetLife, Inc. (MET) has filed a Form 8-K to provide investors with preliminary insights into its variable investment income for the quarter ending June 30, 2026. The company estimates this income to be in the range of $220 million to $270 million (pre-tax). This preliminary figure offers a mid-quarter update ahead of the official earnings release scheduled for August 5, 2026, which will include the full quarterly financial supplement. This disclosure is important for investors tracking MetLife's diversified income streams, particularly those derived from private equity, real estate, and other funds, as well as prepayment fees. While this information is preliminary and unaudited, it provides a directional indication compared to the company's full-year 2026 guidance of approximately $1.6 billion (pre-tax) for variable investment income. Investors should exercise caution as actual results may differ materially, and this data should not replace the comprehensive financial statements.
METLIFE INC 8-K Report, Shareholder Vote Results (Jun 22, 2026)
MetLife, Inc. (MET) reported the results of its annual meeting of common shareholders held on June 16, 2026. The filing indicates strong shareholder support for the company's governance and executive compensation practices. All eleven director nominees were elected, and the appointment of Deloitte & Touche LLP as the independent auditor for 2026 was ratified with a substantial majority of votes. Additionally, shareholders provided advisory approval for the compensation of Named Executive Officers, signaling confidence in the company's leadership and compensation structure. These results suggest a stable shareholder base that is largely aligned with the current board and management. The overwhelming support for director elections and auditor ratification underscores a healthy corporate governance framework. Investors can view these outcomes as positive indicators of continuity and trust in MetLife's operational and strategic direction.
METLIFE INC 8-K Report, Corporate Update (May 15, 2026)
MetLife, Inc. (MET) has filed an 8-K report on May 15, 2026, primarily announcing the declaration of quarterly dividends on its various series of preferred stock. Investors focused on income generation or holding these preferred securities should note the specific dividend amounts declared for Series A, Series E, and Series F preferred stock. While this filing does not disclose material changes in financial performance or strategic direction, it confirms the company's ongoing commitment to returning capital to its preferred shareholders.
METLIFE INC 8-K Report, Financial Results (May 6, 2026)
MetLife Inc. has filed an 8-K on May 6, 2026, primarily to report its financial results for the quarter ended March 31, 2026. The filing includes an Earnings Release, a Quarterly Financial Supplement, and a Total Assets Under Management (AUM) Fact Sheet, all of which provide detailed financial performance data for the specified period. Additionally, an Earnings Call Presentation was issued, offering further insights and context based on the released financial information and prior disclosures. While this 8-K does not contain new material events, it serves as a crucial disclosure vehicle for investors to access MetLife's most recent financial performance metrics. Investors should refer to the attached exhibits, particularly the Earnings Release and Quarterly Financial Supplement, for a comprehensive understanding of the company's operational and financial condition as of and for the first quarter of 2026.
METLIFE INC 8-K Report, Regulation FD Disclosure (Apr 7, 2026)
MetLife, Inc. (MET) has filed a Form 8-K to provide preliminary guidance on its variable investment income for the first quarter of 2026. The company estimates this income, which includes returns from private equity, real estate, and other funds, as well as prepayment fees, to be between $475 million and $525 million on a pre-tax basis. This figure is part of the company's previously issued full-year 2026 guidance of approximately $1.6 billion in variable investment income. While this provides early insight into a key component of MetLife's investment performance, investors are cautioned that these numbers are preliminary, unaudited, and based on information available as of the filing date. Actual results could differ materially once full financial closing procedures are completed. The company emphasizes that this disclosure should not be seen as a substitute for their full U.S. GAAP financial statements and that no inferences should be drawn about other financial or operating data not provided here.
METLIFE INC 8-K Report, Corporate Update (Mar 5, 2026)
MetLife, Inc. (MET) filed an 8-K on March 5, 2026, primarily to confirm the previously announced declaration of its first quarter 2026 dividend for its floating rate non-cumulative preferred stock, Series A. The dividend is set at $0.31501229 per share, based on a $25 liquidation preference. This filing serves as a confirmation and does not introduce new financial results or material operational updates beyond the dividend declaration. Investors holding this specific series of preferred stock should note this confirmation regarding their expected dividend payment for the first quarter of 2026.
METLIFE INC 8-K Report, Financial Obligation (Feb 26, 2026)
MetLife Inc. has announced the issuance of $1 billion in 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056. This debt issuance, finalized on February 26, 2026, was conducted under the company's existing shelf registration statement and a recently filed prospectus supplement. The funds raised are expected to support MetLife's ongoing business operations and strategic initiatives. From an investor's perspective, this subordinated debt issuance represents a new layer of leverage for MetLife. While offering a fixed coupon rate initially, the 'Fixed-to-Fixed Reset Rate' feature implies potential adjustments to the interest rate over the life of the debentures. Investors should note the subordinated nature of these debentures, meaning they rank below senior debt in the event of liquidation. The details of the underwriting and pricing agreements with major financial institutions indicate a well-structured offering.
METLIFE INC 8-K Report, Executive Changes (Feb 24, 2026)
MetLife, Inc. (MET) announced a significant change to its Board of Directors on February 24, 2026, by increasing the board size from eleven to thirteen members and appointing two new independent directors, Daniel S. Glaser and Michelle R. Seitz. Both directors have been immediately assigned to key board committees, reflecting their expertise and the company's strategic focus on governance, risk, compensation, and investment oversight. This expansion and appointment of experienced individuals are intended to enhance the board's capabilities and provide diverse perspectives crucial for navigating the complex financial services landscape.
METLIFE INC 8-K Report, Corporate Update (Feb 17, 2026)
MetLife, Inc. (MET) has filed an 8-K report on February 17, 2026, primarily announcing the declaration of various preferred stock dividends. Investors should note the specific dividend amounts and frequencies for Series D, Series E, Series F, and Series A preferred stock. The declaration of these dividends indicates the company's ongoing commitment to returning capital to its shareholders, a positive sign for preferred stockholders.
METLIFE INC 8-K Report, Financial Results (Feb 4, 2026)
MetLife, Inc. has filed an 8-K report on February 4, 2026, detailing its financial results for the quarter and full year ended December 31, 2025, and providing an outlook for 2026. The company's outlook acknowledges continued economic uncertainty regarding inflation and unemployment, while expecting a relatively stable U.S. dollar and a moderate rise in long-term interest rates with a steepening yield curve in 2026. MetLife highlights its robust capital position, maintaining $3.6 billion in holding company cash, within its target range, and reiterates its commitment to returning capital to shareholders, having returned approximately $4.4 billion in 2025 and remaining on track to generate $25.0 billion in free cash flow over the 2025-2029 period.
METLIFE INC 8-K Report, Regulation FD Disclosure (Jan 9, 2026)
MetLife, Inc. (MET) has announced a significant organizational restructuring effective in the fourth quarter of 2025, aimed at accelerating growth in its asset management business. The key change involves elevating MetLife Investment Management (MIM) to a standalone reportable segment. Previously, MIM was housed within 'Corporate & Other'. This move is intended to provide greater visibility and focus on the company's institutional asset management capabilities. In conjunction with this, MetLife Holdings will no longer be a reportable segment and its results will primarily be integrated into 'Corporate & Other'. Additionally, certain product lines formerly within MetLife Holdings have been realigned into the Group Benefits and Retirement and Income Solutions (RIS) segments. These segment changes have been applied retrospectively to prior periods for enhanced comparability. The company also adjusted inter-company management fee agreements for MIM to reflect current market rates, a change also applied retrospectively. Importantly, these organizational and accounting adjustments did not impact prior consolidated net income or adjusted earnings.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 30, 2025)
MetLife, Inc. (MET) has filed an 8-K report on December 30, 2025, announcing the successful closing of its acquisition of PineBridge Investments, LLC and its affiliates by MetLife Investment Management. This strategic move significantly expands MetLife's investment management capabilities and assets under management. The company also released a pro forma fact sheet detailing the combined total assets under management (AUM) as if the acquisition had occurred on September 30, 2025. This information provides investors with a clear picture of the scale and potential impact of this significant transaction on MetLife's investment arm.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 22, 2025)
MetLife, Inc. has filed an 8-K report to provide investors with a preliminary update on its financial performance and outlook for the fiscal year ending December 31, 2025, ahead of its official earnings release. The company anticipates variable investment income for the fourth quarter of 2025 to be between $385 million and $435 million (pre-tax), slightly below its quarterly target of $425 million, but expects its full-year 2025 variable investment income to be around $1.7 billion (pre-tax). In terms of capital management, MetLife is prioritizing organic growth, with an estimated $4 billion deployed in 2025, and an additional $1 billion for M&A, including the pending acquisition of PineBridge Investments. The company also expects to repurchase approximately $2.85 billion of its common stock in 2025, a level it anticipates maintaining in 2026. Investors should note that this information is preliminary and unaudited, and actual results could materially differ.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 1, 2025)
MetLife, Inc. has announced the completion of a significant reinsurance transaction with Talcott Resolution Life Insurance Company. This transaction involves approximately $10 billion of U.S. retail variable annuity and rider reserves. The reinsurance agreement aims to reduce MetLife's exposure to certain legacy blocks of business, potentially improving capital efficiency and strategic focus. Investors should view this as a move to de-risk the balance sheet and free up capital for other strategic initiatives or shareholder returns.
METLIFE INC 8-K Report, Corporate Update (Nov 17, 2025)
MetLife, Inc. (MET) has filed an 8-K Current Report on November 17, 2025, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing is important for preferred stockholders as it confirms the payment of regular dividends for Series A, Series E, and Series F preferred stock. Investors should note that these are dividend declarations, indicating the company's continued commitment to returning capital to its shareholders.
METLIFE INC 8-K Report, Financial Results (Nov 5, 2025)
MetLife, Inc. has filed an 8-K report on November 5, 2025, primarily to furnish investors with their third-quarter 2025 financial results. The filing includes a news release detailing the earnings for the quarter ended September 30, 2025, a supplementary financial report, and a fact sheet on total assets under management (AUM) as of the same date. Additionally, a supplemental slide presentation has been provided, offering further insights into the company's performance and relevant prior disclosures. While this 8-K does not contain new material events or definitive financial statements in the traditional sense, it serves as a crucial communication channel for investors to access the latest operational and financial condition updates. Investors should review the accompanying exhibits, particularly the Earnings Release and Quarterly Financial Supplement, for specific details on revenue, profitability, AUM growth, and any management commentary on business performance and outlook.
METLIFE INC 8-K Report, Bylaw Amendment (Oct 14, 2025)
MetLife Inc. (MET) has filed a Current Report (8-K) detailing the elimination of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G. This action, effective October 14, 2025, follows the complete redemption, repurchase, or reacquisition of all outstanding shares of this preferred stock. The filing with the Delaware Secretary of State formally removes the Series G Preferred Stock provisions from MetLife's Amended and Restated Certificate of Incorporation. From an investor's perspective, this filing indicates a simplification of MetLife's capital structure. The elimination of this specific series of preferred stock suggests the company has managed its outstanding liabilities and financial obligations effectively. While this event does not involve new financial performance metrics or strategic shifts, it represents a housekeeping item that tidies up the company's corporate governance and share structure, potentially reducing administrative complexity.
METLIFE INC 8-K Report, Regulation FD Disclosure (Sep 22, 2025)
MetLife, Inc. (MET) has filed a Form 8-K to provide investors with preliminary insights into its estimated variable investment income for the quarter ending September 30, 2025. The company anticipates that this income will meet its quarterly target of $425 million (pre-tax). This figure is part of MetLife's full-year guidance of approximately $1.7 billion (pre-tax) for variable investment income, which includes returns from private equity, real estate, other funds, and prepayment fees. It is crucial for investors to understand that this information is preliminary, unaudited, and based on data available as of the filing date. MetLife has not completed its financial closing procedures for the quarter, and actual results may differ materially. Investors should exercise caution and avoid drawing conclusions about other financial or operating data not provided in this disclosure. This preliminary data should not be considered a substitute for the comprehensive financial statements prepared under U.S. GAAP or indicative of future performance.
METLIFE INC 8-K Report, Corporate Update (Sep 15, 2025)
MetLife, Inc. (MET) has filed an 8-K to disclose receipt of an unsolicited "mini-tender" offer from Potemkin Limited to purchase up to 10,000 shares of common stock at $53.00 per share. This offer price represents a significant discount of approximately 34.42% compared to the recent closing price of $80.82 on September 12, 2025. MetLife, Inc. explicitly states that it does not endorse this offer and is not affiliated with Potemkin Limited. The company is actively advising its shareholders to reject the offer and not tender their shares. The shares targeted by this offer represent a minuscule fraction of the company's outstanding stock, underscoring the limited impact this specific offer is likely to have on the overall shareholder base. Investors should exercise caution and carefully review the terms of any unsolicited offer.
METLIFE INC 8-K Report, Corporate Update (Sep 2, 2025)
MetLife, Inc. (MET) announced on September 2, 2025, via an 8-K filing, its intention to redeem all outstanding shares of its 3.850% fixed rate reset non-cumulative preferred stock, Series G. This redemption will occur on September 15, 2025, with each share being bought back at its liquidation preference of $1,000 per share. Investors holding Series G Preferred Stock should note that the final semi-annual dividend of $19.250 per share will be paid on the redemption date, September 15, 2025, to shareholders of record as of August 29, 2025. This dividend is separate from and not included in the $1,000 redemption price.
METLIFE INC 8-K Report, Corporate Update (Aug 15, 2025)
MetLife Inc. (MET) has filed an 8-K report detailing the declaration of various preferred stock dividends, as announced in a news release dated August 15, 2025. The report primarily serves to inform investors about the company's commitment to returning capital through regular dividend payments across its preferred stock series. Investors should note the different dividend frequencies (quarterly and semi-annual) and rates associated with each preferred stock series. These declarations are routine and reflect MetLife's ongoing financial management and capital allocation strategies, reinforcing its financial stability and dedication to preferred shareholders. The filing itself does not indicate any significant new business developments or changes in financial performance beyond these dividend announcements.
METLIFE INC 8-K Report, Financial Results (Aug 6, 2025)
MetLife, Inc. (MET) has filed an 8-K Current Report on August 6, 2025, announcing its financial results for the quarter ended June 30, 2025. The report primarily incorporates by reference a series of supplemental documents, including the company's Earnings Release, a Quarterly Financial Supplement, and a Total Assets Under Management (AUM) Fact Sheet. These documents, along with a supplemental slide presentation, provide investors with a comprehensive overview of MetLife's performance and financial condition for the most recent quarter. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached exhibits for critical information. Investors should review the Earnings Release and Quarterly Financial Supplement for specific metrics such as revenue, net income, earnings per share, and segment performance. The Total AUM Fact Sheet will offer insights into the scale of MetLife's investment management capabilities as of the end of the second quarter.
METLIFE INC 8-K Report, Executive Changes (Jul 30, 2025)
MetLife, Inc. (MET) has announced a significant executive appointment, naming Adrienne O’Neill as its new Executive Vice President and Chief Accounting Officer, effective September 2, 2025. This appointment brings a seasoned financial executive with extensive experience in accounting, investor relations, and various segments of the financial services industry from her tenure at Manulife Financial Corporation. Investors should note her comprehensive background, which includes roles such as CFO of Asia Segment and Global Controller. Ms. O’Neill's compensation package reflects her seniority and the transition, including a base salary of $525,000, eligibility for discretionary incentive awards, pro-rated for 2025, and substantial sign-on awards totaling $1,950,000 in cash and stock. These sign-on awards are designed to offset forfeited compensation from her previous employer. The report also clarifies that the current interim Chief Accounting Officer, Toby Srihiran Brown, will transition back to his role as Executive Vice President and Global Head of Reinsurance. This filing does not indicate any related-party transactions or arrangements concerning Ms. O’Neill's appointment.
METLIFE INC 8-K Report, Regulation FD Disclosure (Jul 1, 2025)
MetLife, Inc. (MET) has announced a significant reinsurance agreement with Chariot Reinsurance, Ltd., aimed at transferring approximately $10 billion of its liabilities. This transaction covers structured settlement annuity contracts and group annuity contracts related to pension risk transfers. The agreement is designed to reduce MetLife's exposure to these specific blocks of business, potentially enhancing its financial flexibility and capital position. Investors should view this as a strategic move to manage risk and optimize its balance sheet by offloading a substantial portion of these long-duration liabilities.
METLIFE INC 8-K Report, Regulation FD Disclosure (Jun 23, 2025)
MetLife Inc. (MET) has filed a Form 8-K to provide a preliminary, unaudited estimate of its variable investment income for the quarter ending June 30, 2025. The company anticipates variable investment income to be in the range of $175 million to $225 million (pre-tax). This disclosure is intended to offer early insight into a specific component of their expected financial performance ahead of the official earnings release and quarterly financial supplement scheduled for August 6, 2025. Investors should note that this information is preliminary and has not undergone the full financial closing procedures. Consequently, actual results could differ materially from these estimates. This disclosure is furnished under Regulation FD and is not intended to be a substitute for the comprehensive financial statements that will be filed later in accordance with U.S. GAAP, nor should it be used to infer other financial or operating data. Investors are advised to exercise caution when relying on this preliminary data.
METLIFE INC 8-K Report, Shareholder Vote Results (Jun 20, 2025)
MetLife, Inc. (MET) has filed an 8-K report detailing the outcomes of its annual meeting of common shareholders held on June 17, 2025. The key resolutions passed include the election of eleven directors for terms expiring at the 2026 annual meeting, the ratification of Deloitte & Touche LLP as the company's independent auditor for 2025, and an advisory approval of the compensation for Named Executive Officers. All director nominees received a substantial majority of "For" votes, indicating strong shareholder confidence in the current board. The ratification of the auditor and the advisory vote on executive compensation also saw significant shareholder approval, with "For" votes outnumbering "Against" votes by a wide margin in both cases. These results suggest a stable governance framework and continued shareholder support for the company's leadership and its chosen auditors. The "Broker Non-Votes" noted in the director elections represent shares held by brokers where the beneficial owner did not provide voting instructions. While these do not count for or against a proposal, their presence is standard in many shareholder meetings and does not appear to have impacted the decisive outcomes for the director elections or other proposals. Investors can view these outcomes as a positive sign of established corporate governance practices at MetLife.
METLIFE INC 8-K Report, Financial Obligation (Jun 17, 2025)
MetLife Inc. (MET) has announced the issuance of ¥87.84 billion (approximately $790 million USD as of June 2025, based on typical exchange rates) in yen-denominated senior notes through a private placement. This offering consists of six tranches with varying maturities ranging from 2032 to 2055 and coupon rates between 2.14% and 3.62%. The proceeds are earmarked for refinancing existing debt, specifically ¥25.2 billion of senior notes maturing in 2026, and for general corporate purposes. This transaction diversifies MetLife's funding sources and potentially extends its debt maturity profile. The issuance in a foreign currency indicates a strategic move to manage currency exposures or access international capital markets. While the notes are not registered under the Securities Act, they were offered in reliance on an exemption for private placements, a common practice for large corporate debt issuances. Investors should note that these are senior unsecured obligations of MetLife, Inc.
METLIFE INC 8-K Report, Corporate Update (May 15, 2025)
MetLife, Inc. (MET) has filed an 8-K report detailing the declaration of its quarterly preferred stock dividends. This filing, dated May 14, 2025, and announced on May 15, 2025, confirms ongoing dividend payments for three series of preferred stock, including Series A (floating rate), Series E (5.625%), and Series F (4.75%). For investors holding these preferred securities, the key takeaway is the continued commitment to distributing dividends as per the established terms. The specific dividend amounts per share have been clearly outlined for each series, providing transparency for shareholders regarding their expected income from these preferred stock holdings. The filing itself primarily serves as a formal announcement and does not contain new financial performance data, but rather confirms a routine financial action.
METLIFE INC 8-K Report, Financial Results (Apr 30, 2025)
MetLife, Inc. has filed an 8-K report detailing its financial and operational updates for the quarter ended March 31, 2025. The report includes the release of its earnings, a quarterly financial supplement, and a fact sheet on assets under management (AUM). These documents provide a comprehensive view of the company's performance and financial position during the period. Key investor information includes the announcement of a new $3.0 billion stock repurchase authorization by the Board of Directors, signaling a commitment to returning capital to shareholders. While the specific financial results for the quarter are detailed in the furnished exhibits, this 8-K serves as the official notification and provides access to the detailed financial reporting, including AUM figures and supplemental slides for further analysis.
METLIFE INC 8-K Report, Regulation FD Disclosure (Apr 30, 2025)
MetLife, Inc. (MET) has announced a significant strategic move through a reinsurance agreement with Talcott Resolution Life Insurance Company, effective April 30, 2025. This agreement involves reinsuring approximately $10 billion of U.S. retail variable annuity and rider reserves. This transaction is designed to de-risk MetLife's balance sheet by reducing its exposure to these long-duration liabilities. Investors should view this as a step towards enhancing capital efficiency and potentially improving financial flexibility as the company shifts its focus and capital allocation strategies.
METLIFE INC 8-K Report, Executive Changes (Mar 28, 2025)
MetLife, Inc. (MET) has filed an 8-K report on March 27, 2025, primarily announcing the resignation of director David L. Herzog. Mr. Herzog will step down from the Board of Directors effective May 1, 2025, and will not seek re-election at the upcoming annual meeting. Importantly, the company has stated that Mr. Herzog's decision is not due to any disagreements regarding the Company's operations, policies, or practices. This event is considered routine and does not appear to signal any significant underlying issues with the company's governance or business operations at this time. Investors should monitor future board composition and any potential strategic implications arising from changes in board membership.
METLIFE INC 8-K Report, Financial Obligation (Mar 13, 2025)
MetLife Inc. (MET) has filed an 8-K report detailing the issuance of $1 billion in 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055. This issuance was conducted under the company's existing shelf registration statement and a related prospectus supplement, with the transaction finalized on March 13, 2025. The purpose of this issuance is to raise capital, likely to bolster its financial flexibility and support its ongoing business operations. A significant event accompanying this debt issuance is the termination of the company's Replacement Capital Covenants. These covenants, originally established in connection with earlier debt issuances, were tied to specific "covered debt." The newly issued debentures now qualify as "covered debt," and the holders of these new debentures have consented to the termination of the prior covenants. This action simplifies MetLife's debt structure and removes past obligations associated with these covenants.
METLIFE INC 8-K Report, Corporate Update (Mar 5, 2025)
MetLife Inc. (MET) filed an 8-K on March 5, 2025, primarily to confirm the previously announced declaration of its first quarter 2025 dividend for its floating rate non-cumulative preferred stock, Series A. This dividend is set at $0.35516415 per share, with a liquidation preference of $25 per share. The filing serves as an official record of this distribution, providing clarity to preferred stockholders regarding their upcoming payment. While this filing does not contain new financial results or significant operational updates, it reinforces MetLife's commitment to returning capital to its shareholders through regular dividend payments on its preferred stock. Investors holding this specific series of preferred stock can expect the declared dividend to be paid as scheduled. The news release attached as an exhibit further details this declaration.
METLIFE INC 8-K Report, Financial Obligation (Mar 4, 2025)
MetLife Inc. (MET) has announced the completion of a private placement of $1.25 billion in Pre-Capitalized Trust Securities (P-Caps) maturing in 2055. These P-Caps serve as a contingent funding arrangement, providing MetLife with the right to issue up to $1.25 billion in 5.740% Senior Notes due 2055 to the Trust over a thirty-year period. The proceeds from the P-Cap issuance were invested by the Trust in U.S. Treasury securities, effectively securing the future obligation. This transaction establishes a forward-looking financing mechanism that strengthens MetLife's capital structure and provides a predetermined cost of capital for future debt issuance. While the P-Caps are restricted to qualified institutional buyers, the arrangement itself offers MetLife flexibility in managing its long-term liabilities and interest rate exposure. The company will pay a semi-annual facility fee on the unexercised portion of the Issuance Right, with specific triggers for automatic or mandatory exercise of the Senior Notes issuance.
METLIFE INC 8-K Report, Executive Changes (Feb 27, 2025)
MetLife Inc. (MET) announced a change in its Chief Accounting Officer role and an expansion of its Board of Directors in a recent 8-K filing. Effective March 15, 2025, Toby Srihiran Brown will assume the interim Chief Accounting Officer (CAO) position, succeeding Tamara L. Schock who previously indicated her intent to resign. Mr. Brown brings extensive experience within MetLife, having held various senior finance and operational roles, including his current position as Executive Vice President and Global Head of Reinsurance. This transition is part of an ongoing search for a permanent CAO. Furthermore, the Board of Directors has been expanded to fourteen members with the appointment of Christian Mumenthaler, effective May 1, 2025. Mr. Mumenthaler, who has been deemed an independent director, will serve on the Finance and Risk Committee and the Investment Committee. He will be compensated under the standard non-management director compensation plan, which includes a combination of stock and cash.
METLIFE INC 8-K Report, Corporate Update (Feb 18, 2025)
MetLife Inc. (MET) has filed an 8-K report detailing the declaration of several preferred stock dividends, as announced in a news release dated February 18, 2025. This filing is primarily focused on returning capital to preferred shareholders, indicating the company's ongoing commitment to its dividend policies. Investors should note the specific dividend amounts and frequencies for various preferred stock series, which provide a degree of income predictability for holders of these securities. While this report primarily concerns dividend declarations, it's important for common shareholders to understand how these preferred dividends impact overall financial flexibility and potential distributions to common stock. The declaration suggests MetLife is in a position to meet its preferred dividend obligations, which is a positive indicator of financial stability. Investors should monitor any further announcements regarding common stock dividends or share repurchases in conjunction with these preferred dividend declarations.
METLIFE INC 8-K Report, Financial Results (Feb 5, 2025)
MetLife, Inc. (MET) has filed an 8-K report on February 5, 2025, detailing its financial results for the fourth quarter and full year ended December 31, 2024, alongside its strategic outlook for 2025 and beyond. The report includes the company's earnings release, a quarterly financial supplement, and an asset under management fact sheet. A key takeaway for investors is the company's "New Frontier" five-year strategy, designed to accelerate growth and deliver attractive, all-weather returns, building on the success of its prior "Next Horizon" strategy. The company's outlook for 2025 anticipates continued economic uncertainties, including inflation and unemployment, and a strengthening U.S. dollar. Despite these challenges, MetLife projects stable long-term interest rates with a steepening yield curve as short-term rates decline, and it expresses confidence in its diversified investment portfolio's ability to perform across various economic scenarios. Furthermore, MetLife highlighted its strong liquidity position, exceeding its holding company cash target, and its ongoing commitment to returning capital to shareholders, with significant free cash flow generation expected over the next five years.
METLIFE INC 8-K Report, Executive Changes (Jan 10, 2025)
MetLife Inc. (MET) announced the upcoming resignation of Tamara L. Schock, Executive Vice President and Chief Accounting Officer, effective on or about March 14, 2025. Ms. Schock's departure is attributed to personal reasons and is not a result of any disagreements with the company regarding its financial reporting, internal controls, operations, or policies. This change in a key financial leadership role may warrant investor attention as the company navigates its succession planning and ensures a smooth transition in its accounting oversight. While the report does not disclose any immediate financial impacts or strategic shifts stemming from this departure, investors should monitor future communications from MetLife for updates on the appointment of a successor and any potential effects on the company's financial reporting processes. The filing confirms that the resignation is not indicative of any underlying issues with the company's financial statements or internal controls.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 12, 2024)
MetLife, Inc. has filed an 8-K report to announce its upcoming Investor Day on December 12, 2024, where the company will unveil its "New Frontier" growth strategy and outline long-term financial commitments. This strategic initiative signals a forward-looking approach to business development and capital allocation, which investors will want to closely monitor for potential impacts on future performance and shareholder returns. The accompanying press release and presentation slides, furnished as exhibits to this filing, provide the core details of this new strategy. Investors should pay close attention to the specifics of the New Frontier strategy, including any new market focus, product innovations, or operational efficiencies MetLife intends to pursue. The long-term financial commitments will be particularly important in understanding the company's expected trajectory regarding profitability, capital deployment, and potentially dividend or share repurchase policies. This event represents a key opportunity for investors to gain deeper insights into MetLife's strategic direction and its implications for the company's competitive positioning and financial health.
METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 11, 2024)
MetLife, Inc. (MET) announced on December 11, 2024, the anticipated launch of Chariot Reinsurance, Ltd. ("Chariot Re"), a new third-party offshore reinsurance company. This venture, developed in partnership with General Atlantic, will leverage MetLife Investment Management and General Atlantic as asset managers, with both entities making minority equity investments in Chariot Re. MetLife has secured conditional approval from the Bermuda Monetary Authority for registration in Bermuda, indicating significant progress towards the launch targeted for the first half of 2025, pending regulatory approvals and other closing conditions. This strategic initiative involves MetLife initially ceding approximately $10 billion of statutory reserves related to structured settlement and group annuity contracts from pension risk transfers to Chariot Re. The company anticipates this transaction will result in an estimated increase of approximately $1 billion in available capital. Investors should view this as a move to enhance capital efficiency and potentially de-risk a portion of its balance sheet by transferring specific annuity liabilities to a new reinsurance entity.
METLIFE INC 8-K Report, Corporate Update (Nov 15, 2024)
MetLife, Inc. (MET) filed an 8-K report on November 15, 2024, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing serves as an update for investors regarding the company's commitment to returning capital through dividend distributions. The company declared dividends for three series of preferred stock: Series A (floating rate non-cumulative), Series E (5.625% non-cumulative), and Series F (4.75% non-cumulative). The specific dividend amounts per share for each series were detailed, providing clarity on the expected payouts to preferred stockholders. This action underscores MetLife's ongoing financial stability and its strategy to reward its investors.
METLIFE INC 8-K Report, Financial Results (Oct 30, 2024)
MetLife Inc. (MET) filed an 8-K on October 30, 2024, to announce its financial results for the quarter ended September 30, 2024. The filing includes a press release detailing the company's operational and financial performance, a supplemental quarterly financial report, and a fact sheet on assets under management (AUM). This report is crucial for investors seeking to understand MetLife's recent financial standing and operational highlights. While the 8-K itself does not contain detailed financial figures, it directs investors to accompanying exhibits for comprehensive data. These exhibits provide the earnings release, a detailed quarterly financial supplement, and information on total assets under management as of the end of the third quarter. Additionally, a supplemental slide presentation offers further insights and context to the reported results, aiding investors in their analysis of MetLife's performance and strategic positioning.
METLIFE INC 8-K Report, Financial Obligation (Sep 30, 2024)
MetLife Inc. (MET) filed an 8-K on September 29, 2024, detailing the issuance of an additional $250 million in 5.300% Senior Notes due 2034. This issuance, which occurred on September 30, 2024, was conducted under the Company's existing shelf registration statement and supplements a prior issuance of the same notes. The primary purpose of this filing is to report a new direct financial obligation. Investors should note that this $250 million debt issuance increases the Company's overall leverage. The fixed interest rate of 5.300% on these notes will contribute to ongoing interest expenses. The full terms and conditions of these notes and the related indentures are incorporated by reference into this filing.
METLIFE INC 8-K Report, Corporate Update (Aug 15, 2024)
MetLife Inc. (MET) filed an 8-K on August 15, 2024, primarily to announce the declaration of various preferred stock dividends. The report details the payment of quarterly dividends for Series A, Series E, and Series F preferred stock, as well as semi-annual dividends for Series D and Series G preferred stock. This announcement is routine for the company and provides clarity on upcoming distributions to preferred shareholders. For common shareholders, this filing does not contain information regarding common stock dividends or material business updates. Investors should view this 8-K as a standard operational disclosure concerning MetLife's commitment to its preferred stockholders, with no immediate implications for the company's overall financial performance or strategic direction indicated in this specific report. The details provided are for informational purposes regarding dividend payouts on specific preferred stock series.
METLIFE INC 8-K Report, Financial Results (Jul 31, 2024)
MetLife Inc. (MET) filed an 8-K report on July 31, 2024, primarily announcing its financial results for the quarter ended June 30, 2024. The filing incorporates by reference a news release (Exhibit 99.1), a Quarterly Financial Supplement (Exhibit 99.2), and a Total Assets Under Management (AUM) Fact Sheet (Exhibit 99.3). These documents provide detailed operational and financial condition information for the period. The company also furnished a supplemental slide presentation (Exhibit 99.4) to highlight key information from these reports and prior disclosures.
METLIFE INC 8-K Report, Executive Changes (Jun 24, 2024)
MetLife Inc. (MET) filed an 8-K on June 24, 2024, detailing key outcomes from its annual shareholder meeting on June 18, 2024. The most significant developments for investors revolve around the approval of new long-term and annual incentive compensation plans. Shareholders overwhelmingly approved the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, which will govern equity-based awards to employees and directors starting January 1, 2025. Additionally, the Board of Directors approved the MetLife Annual Variable Incentive Plan (AVIP) for performance periods commencing on or after January 1, 2025, which will provide for annual cash incentive awards based on established criteria. Beyond compensation plan updates, the meeting saw the election of thirteen Directors to serve until the 2025 annual meeting. The appointment of Deloitte & Touche LLP as the independent auditor for 2024 was ratified. Shareholders also provided an advisory vote of approval for the compensation paid to Named Executive Officers. Notably, a shareholder proposal requesting a third-party racial equity audit was not approved.
METLIFE INC 8-K Report, Financial Obligation (Jun 5, 2024)
MetLife Inc. (MET) has filed an 8-K report announcing the issuance of $500 million in Senior Notes due in 2034, carrying a coupon rate of 5.300%. This debt issuance was conducted under the company's existing shelf registration statement and a related prospectus supplement. The proceeds from these notes are expected to be used for general corporate purposes. This move indicates MetLife's active management of its capital structure and its ability to access public debt markets. Investors should note that the issuance of new debt increases the company's leverage. The specific use of proceeds for general corporate purposes suggests flexibility in how the company plans to deploy these funds, which could include operational needs, strategic investments, or refinancing existing obligations. The long-term nature of these notes (10-year maturity) implies a strategic approach to funding.
METLIFE INC 8-K Report, Corporate Update (May 15, 2024)
MetLife, Inc. (MET) filed an 8-K report on May 15, 2024, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing confirms the continuation of dividend payments for its Series A, Series E, and Series F preferred stock. For investors holding these specific preferred securities, this report provides confirmation of their upcoming dividend payouts. While this 8-K is limited in scope and does not contain material updates on the company's overall financial performance or strategic initiatives, it signals MetLife's ongoing commitment to returning capital to its shareholders through regular dividend distributions. Investors should note that these dividends pertain to preferred stock and are distinct from any common stock dividends the company may issue.
METLIFE INC 8-K Report, Financial Results (May 1, 2024)
MetLife Inc. (MET) filed an 8-K on May 1, 2024, reporting its first-quarter 2024 results. The filing primarily includes earnings releases, a quarterly financial supplement, and a fact sheet detailing assets under management as of March 31, 2024. While the specific financial figures for the quarter are not detailed within the 8-K itself, these accompanying documents provide the comprehensive results investors will need to assess the company's performance. Investors should review these exhibits for detailed financial performance metrics and operational updates for the period.
METLIFE INC 8-K Report, Corporate Update (Mar 12, 2024)
MetLife Inc. announced on March 12, 2024, its intention to redeem all outstanding 5.375% Senior Notes due December 9, 2024. This redemption, totaling £350 million in principal, is scheduled for April 11, 2024, and is being executed in accordance with the terms of the notes. Investors holding these specific notes should be aware of this early repayment. The company has provided this information through a news release, which is attached to the 8-K filing. While this filing serves as an announcement, it is important to note that it does not constitute the official notice of redemption itself. Shareholders and noteholders should refer to official notices for definitive details regarding the redemption process.